Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02607150 · ClinicalTrials.gov registry record

Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood

A clinical trial, sponsored by Nationwide Children's Hospital.

Completed
Registry status
50
Enrollment target

NCT02607150 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02607150 has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

A prospective study designed to evaluate changes in tissue and cerebral oxygenation before and following administration of blood for patients undergoing spinal surgery. Red blood transfusions (autologous and allogeneic) are indicated to improve oxygen delivery to the tissues and hence tissue oxygenation. Despite the presumed efficacy, there are limited data to demonstrate changes in tissue oxygenation with the administration of blood. Furthermore, the administration of both autologous blood from cell saver and allogeneic blood can be associated with both acute and long-term deleterious physiologic effects which may impact the perioperative course. As such, data are needed to clearly delineate the benefits of transfusion during the perioperative period.

Interventions

  • OTHER Cerebral Oxygenation Changes

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-12
Est. Completion 2016-03

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT02607150

The ClinicalTrials.gov registry entry for NCT02607150 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cerebral Oxygenation Changes is the first listed.

NCT02607150 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02607150 about?

NCT02607150 is a clinical study titled "Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood". A prospective study designed to evaluate changes in tissue and cerebral oxygenation before and following administration of blood for patients undergoing spinal surgery. Red blood transfusions (autologous and allogeneic) are indicated to improve oxygen delivery to the tissues and hence tissue oxygen...

What is the current status of trial NCT02607150?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-12. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02607150?

The interventions under investigation include: Cerebral Oxygenation Changes (OTHER).

Who is sponsoring clinical trial NCT02607150?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.